Bio-Techne Corporation Reports Q4 2024 Financial Results

Wednesday, 7 August 2024, 14:58
Bio-Techne Corporation (NASDAQ: TECH) has released its financial results for the fourth quarter of 2024, revealing a decrease in profit. Despite a modest organic revenue increase of 1% to $306.1 million and a 2% rise in net sales, earnings per share fell significantly from $0.47 to $0.25. The report indicates ongoing challenges for the company, making it essential for investors to reevaluate their positions going forward.
AlphaStreet
Bio-Techne Corporation Reports Q4 2024 Financial Results

Earnings Overview

Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) released its fourth-quarter financial results for 2024 on Wednesday.

Key Financial Highlights

  • Organic revenue: Increased 1% to $306.1 million
  • Net sales: Grew 2% in the quarter
  • Earnings per share: Declined to $0.25 from $0.47 the previous year

Conclusion

While Bio-Techne experienced slight growth in revenue, the significant drop in earnings per share raises concerns regarding its overall profitability and future growth strategies. Investors should consider this decline when evaluating the company’s financial health.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe